316 related articles for article (PubMed ID: 37632074)
1. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review.
Foka FET; Mufhandu HT
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632074
[TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
3. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
[TBL] [Abstract][Full Text] [Related]
4. Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis.
Mantshonyane L; Roy J; Levy MZ; Wallis CL; Bar K; Godfrey C; Collier A; LaRosa A; Zheng L; Sun X; Gross R
AIDS Patient Care STDS; 2021 Dec; 35(12):467-473. PubMed ID: 34788110
[TBL] [Abstract][Full Text] [Related]
5. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for short-term virologic outcomes among HIV-infected patients undergoing regimen switch of combination antiretroviral therapy.
Chao C; Tang B; Hurley L; Silverberg MJ; Towner W; Preciado M; Horberg M
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1630-6. PubMed ID: 22475276
[TBL] [Abstract][Full Text] [Related]
7. Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China.
Zhou C; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Wu G; Ruan Y
Front Public Health; 2022; 10():800839. PubMed ID: 35186841
[TBL] [Abstract][Full Text] [Related]
8. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review.
SeyedAlinaghi S; Afsahi AM; Moradi A; Parmoon Z; Habibi P; Mirzapour P; Dashti M; Ghasemzadeh A; Karimi E; Sanaati F; Hamedi Z; Molla A; Mehraeen E; Dadras O
AIDS Res Ther; 2023 Oct; 20(1):74. PubMed ID: 37884997
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.
Ribaudo HJ; Smith KY; Robbins GK; Flexner C; Haubrich R; Chen Y; Fischl MA; Schackman BR; Riddler SA; Gulick RM
Clin Infect Dis; 2013 Dec; 57(11):1607-17. PubMed ID: 24046302
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after virologic failure of first-line ART in South Africa.
Murphy RA; Sunpath H; Lu Z; Chelin N; Losina E; Gordon M; Ross D; Ewusi AD; Matthews LT; Kuritzkes DR; Marconi VC;
AIDS; 2010 Apr; 24(7):1007-12. PubMed ID: 20397305
[TBL] [Abstract][Full Text] [Related]
11. Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China.
Yan J; Liu J; Su B; Pan X; Wang Z; Wu J; Zhang J; Ruan Y; Hsi J; Liao L; Shao Y; Xing H
PLoS One; 2016; 11(4):e0154421. PubMed ID: 27119346
[TBL] [Abstract][Full Text] [Related]
12. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
Kiweewa F; Esber A; Musingye E; Reed D; Crowell TA; Cham F; Semwogerere M; Namagembe R; Nambuya A; Kafeero C; Tindikahwa A; Eller LA; Millard M; Gelderblom HC; Keshinro B; Adamu Y; Maswai J; Owuoth J; Sing'oei VC; Maganga L; Bahemana E; Khamadi S; Robb ML; Ake JA; Polyak CS; Kibuuka H
PLoS One; 2019; 14(2):e0211344. PubMed ID: 30721233
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
Tabb ZJ; Mmbaga BT; Gandhi M; Louie A; Kuncze K; Okochi H; Shayo AM; Turner EL; Cunningham CK; Dow DE
AIDS; 2018 Jun; 32(9):1115-1123. PubMed ID: 29438196
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.
Wohl DA; Kendall MA; Feinberg J; Alston-Smith B; Owens S; Chafey S; Marco M; Maxwell S; Benson C; Keiser P; van der Horst C; Jacobson MA;
PLoS One; 2013; 8(11):e78676. PubMed ID: 24260125
[TBL] [Abstract][Full Text] [Related]
15. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
Scott Sutton S; Magagnoli J; Hardin JW
Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
[TBL] [Abstract][Full Text] [Related]
16. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy adherence patterns, virological suppression, and emergence of drug resistance: A nested case-control study from Uganda and South Africa.
Tyagi A; Tong Y; Rabideau DJ; Reynolds Z; De Oliveira T; Lessells R; Amanyire G; Orrell C; Asiimwe S; Chimukangara B; Giandhari J; Pillay S; Haberer JE; Siedner MJ;
Antivir Ther; 2022 Oct; 27(5):13596535221114822. PubMed ID: 36263960
[TBL] [Abstract][Full Text] [Related]
18. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
19. Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
Belaunzarán-Zamudio PF; Naranjo L; Caro-Vega Y; Castillo-Mancilla JR; Camiro-Zuñiga A; Fuentes-García R; Crabtree-Ramírez BE; Sierra-Madero JG
AIDS Res Hum Retroviruses; 2023 Mar; 39(3):136-144. PubMed ID: 36597354
[TBL] [Abstract][Full Text] [Related]
20. Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251.
Robbins GK; Cohn SE; Harrison LJ; Smeaton L; Moran L; Rusin D; Dehlinger M; Flynn T; Lammert S; Wu AW; Safren SA; Reynolds NR
HIV Clin Trials; 2016 Jul; 17(4):165-72. PubMed ID: 27347650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
